Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001520262-26-000103

EVP R&D, Chief Medical Officer sold 9,000 shares at an average $51.51 ($463,621)

  • EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-01 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $19.34 $96,700 82,389 D
2026-07-01 Sale : show line 2 in the form 10b5-1 −8,300 $51.46 $427,129 74,089 D
2026-07-01 Sale : show line 3 in the form 10b5-1 −700 $52.13 $36,492 73,389 D
Open-market sales · 9,000 sh · avg $51.51 · $463,621

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-01 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Buy) −5,000 1,356 D
Loading xslF345X06/form4.xml…